ArriVent BioPharma, Inc. AVBP
Set alert
13.35 USD -1.52 -10.22%
At close · Nov 2
13.35 0.00 0.00%
After hours · Nov 2, 4:33 PM ET
13.26 Day range 14.98
13.35 52-week range 34.74
- YTD
- -33.65%
- 1 year
- -28.72%
- Open
- 14.89
- Prev close
- 14.87
- Mkt cap
- 658.26M
- Vol
- 1.24M
- Avg vol
- 1.19M
- EPS
- -3.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.26
- High
- 14.98
- Forward P/E
- -5.64
- Beta
- 1.35
- Short ratio
- 13.52
- Inst. own
- 100.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 26.34
- 200-d avg
- 27.09
- 1y target
- 22.30
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 22.30 +67.0% upside
Now 13.35
- Target (low)
- 15.00
- Target (mean)
- 22.30
- Target (high)
- 29.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
- Strong buy0
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.07 | -1.22 – -1.00 | -0.83 | -29.0% | 0 | 0.0% | 10 |
| Next quarter | -1.10 | -1.63 – -0.90 | -0.78 | -40.7% | 0 | 0.0% | 10 |
| Current year | -4.21 | -4.94 – -3.90 | -4.32 | +2.6% | 0 | 0.0% | 11 |
| Next year | -3.72 | -4.75 – -3.10 | -4.21 | +11.6% | 6.10M | 0.0% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Oct 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 8, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 7, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 7, 2026 | Jones Trading | Maintained | Buy | Buy |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 7, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 13, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Aug 13, 2026 | BTIG | Reiterated | Buy | Buy |
| May 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 23, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Mar 6, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 6, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 23, 2025 | Cantor Fitzgerald | Initiated | — | Overweight |
| Dec 10, 2025 | BTIG | Initiated | — | Buy |
| Nov 25, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 11, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 12, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 12, 2025 | Citigroup | Maintained | Buy | Buy |
| Jul 22, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 25, 2025 | Clear Street | Initiated | — | Buy |
| Jun 24, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 24, 2025 | Guggenheim | Reiterated | Buy | Buy |
| May 20, 2025 | Jones Trading | Initiated | — | Buy |